Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Sirius XM Holdings Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Sirius XM Holdings Inc trades at $26.51 (market cap $8.87B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Sirius XM Holdings Inc pays a 4.1% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Sirius XM Holdings Inc for 102 Days on average.
| HALO | SIRI | |
|---|---|---|
Market Cap | $12.58B | $8.87B |
Volume | 2,179,278 | 4,324,672 |
Sector | Health | Media |
52-Week High | $115.22 | $32.59 |
52-Week Low | $61.63 | $19.92 |
Typical Hold Time | 1 Days | 102 Days |
Enterprise Value | $14.49B | $18.16B |
Dividend Yield | — | 4.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Sirius XM Holdings (SIRI) trades at $26.33, up 1.46% with mixed technical signals showing neutral momentum. The stock presents attractive valuation metrics with a P/E of 10.57 and P/B of 0.75, though recent earnings have been inconsistent with two misses in the last four quarters. Strong cash flow generation of $1.9B in 2025 supports the company's dividend payments and strategic initiatives, including recent YouTube advertising partnerships and technology leadership appointments.
SIRI offers value investment potential with upside to the $34.43 consensus price target, representing 31% potential return. However, investors face risks from inconsistent earnings performance and competitive pressures in the audio entertainment space. The company's improving balance sheet with debt-to-asset ratio declining to 35.63% provides financial stability, while institutional accumulation signals confidence in the turnaround story.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
